These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 19624771)

  • 1. Circulating and liver tissue levels of retinol-binding protein-4 in non-alcoholic fatty liver disease.
    Schina M; Koskinas J; Tiniakos D; Hadziyannis E; Savvas S; Karamanos B; Manesis E; Archimandritis A
    Hepatol Res; 2009 Oct; 39(10):972-8. PubMed ID: 19624771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinol-binding protein 4: a promising circulating marker of liver damage in pediatric nonalcoholic fatty liver disease.
    Nobili V; Alkhouri N; Alisi A; Ottino S; Lopez R; Manco M; Feldstein AE
    Clin Gastroenterol Hepatol; 2009 May; 7(5):575-9. PubMed ID: 19268270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum retinol binding protein 4 and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.
    Wu H; Jia W; Bao Y; Lu J; Zhu J; Wang R; Chen Y; Xiang K
    Diabetes Res Clin Pract; 2008 Feb; 79(2):185-90. PubMed ID: 17904683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum retinol-binding protein 4 levels in patients with nonalcoholic fatty liver disease.
    Alkhouri N; Lopez R; Berk M; Feldstein AE
    J Clin Gastroenterol; 2009; 43(10):985-9. PubMed ID: 19525859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating retinol-binding protein 4 is associated with the development and regression of non-alcoholic fatty liver disease.
    Wang X; Chen X; Zhang H; Pang J; Lin J; Xu X; Yang L; Ma J; Ling W; Chen Y
    Diabetes Metab; 2020 Apr; 46(2):119-128. PubMed ID: 31078721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver disease.
    Milner KL; van der Poorten D; Xu A; Bugianesi E; Kench JG; Lam KS; Chisholm DJ; George J
    Hepatology; 2009 Jun; 49(6):1926-34. PubMed ID: 19475694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating retinol binding protein 4 levels in nonalcoholic fatty liver disease: a systematic review and meta-analysis.
    Zhou Z; Chen H; Ju H; Sun M
    Lipids Health Dis; 2017 Sep; 16(1):180. PubMed ID: 28931435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of retinol-binding protein 4 with RNA oligonucleotide prevents high-fat diet-induced metabolic syndrome and non-alcoholic fatty liver disease in mice.
    Tan Y; Sun LQ; Kamal MA; Wang X; Seale JP; Qu X
    Biochim Biophys Acta; 2011 Dec; 1811(12):1045-53. PubMed ID: 21983273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum retinol-binding protein 4 is independently associated with pediatric NAFLD and fasting triglyceride level.
    Huang SC; Yang YJ
    J Pediatr Gastroenterol Nutr; 2013 Feb; 56(2):145-50. PubMed ID: 22983378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinol-binding protein 4: a new marker of virus-induced steatosis in patients infected with hepatitis c virus genotype 1.
    Petta S; Cammà C; Di Marco V; Alessi N; Barbaria F; Cabibi D; Caldarella R; Ciminnisi S; Licata A; Massenti MF; Mazzola A; Tarantino G; Marchesini G; Craxì A
    Hepatology; 2008 Jul; 48(1):28-37. PubMed ID: 18506842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinol Binding Protein-4 Levels and Non-alcoholic Fatty Liver Disease: A community-based cross-sectional study.
    Chen X; Shen T; Li Q; Chen X; Li Y; Li D; Chen G; Ling W; Chen YM
    Sci Rep; 2017 Mar; 7():45100. PubMed ID: 28332619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum retinol-binding protein 4 levels are elevated in non-alcoholic fatty liver disease.
    Seo JA; Kim NH; Park SY; Kim HY; Ryu OH; Lee KW; Lee J; Kim DL; Choi KM; Baik SH; Choi DS; Kim SG
    Clin Endocrinol (Oxf); 2008 Apr; 68(4):555-60. PubMed ID: 17941908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum retinol-binding protein 4 in patients with nonalcoholic fatty liver disease: does it have a significant impact on pathogenesis?
    Cengiz C; Ardicoglu Y; Bulut S; Boyacioglu S
    Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):813-9. PubMed ID: 19820404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD).
    Saeed A; Dullaart RPF; Schreuder TCMA; Blokzijl H; Faber KN
    Nutrients; 2017 Dec; 10(1):. PubMed ID: 29286303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans.
    Stefan N; Hennige AM; Staiger H; Machann J; Schick F; Schleicher E; Fritsche A; Häring HU
    Diabetes Care; 2007 May; 30(5):1173-8. PubMed ID: 17259477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum retinol binding protein 4 is associated with visceral fat in human with nonalcoholic fatty liver disease without known diabetes: a cross-sectional study.
    Chang X; Yan H; Bian H; Xia M; Zhang L; Gao J; Gao X
    Lipids Health Dis; 2015 Apr; 14():28. PubMed ID: 25890223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum AFBP levels are elevated in patients with nonalcoholic fatty liver disease.
    Suh JB; Kim SM; Cho GJ; Choi KM
    Scand J Gastroenterol; 2014 Aug; 49(8):979-85. PubMed ID: 24957697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between NAFLD and retinol-binding protein 4 - an updated systematic review and meta-analysis.
    Hu R; Yang X; He X; Song G
    Lipids Health Dis; 2023 Jan; 22(1):8. PubMed ID: 36670387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of combined exercises on the plasma levels of retinol-binding protein 4 and its relationship with insulin resistance and hepatic fat content in postmenopausal women with nonalcoholic fatty liver disease.
    Norouzpour M; Marandi SM; Ghanbarzadeh M; Zare Maivan A
    J Sports Med Phys Fitness; 2022 May; 62(5):684-690. PubMed ID: 33871240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum FGF21 and RBP4 levels in patients with chronic hepatitis C.
    Kukla M; Berdowska A; Stygar D; Gabriel A; Mazur W; Łogiewa-Bazger B; Sobala-Szczygieł B; Bułdak RJ; Rokitka M; Zajęcki W; Kępa L; Sawczyn T; Zwirska-Korczala K
    Scand J Gastroenterol; 2012 Sep; 47(8-9):1037-47. PubMed ID: 22670657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.